General Information of the Compound
Compound ID
CP0429417
Compound Name
N'-[6-chloro-2-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)quinolin-4-yl]ethane-1,2-diamine
    Show/Hide
Structure
Formula
C21H23ClN4
Molecular Weight
366.896
Canonical SMILES
NCCNc1cc(nc2ccc(Cl)cc12)N1CCCc2ccccc2C1
    Show/Hide
InChI
InChI=1S/C21H23ClN4/c22-17-7-8-19-18(12-17)20(24-10-9-23)13-21(25-19)26-11-3-6-15-4-1-2-5-16(15)14-26/h1-2,4-5,7-8,12-13H,3,6,9-11,14,23H2,(H,24,25)
    Show/Hide
InChIKey
IZSKKJDANDBBLE-UHFFFAOYSA-N
Physicochemical Property
logP
4.2116
Rotatable Bonds
4
Heavy Atom Count
26
Polar Areas
54.18
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71255589
ChEMBL ID
CHEMBL4166043
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00459, Fusion glycoprotein F0
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000668 HEp-2 Homo sapiens (Human)  1
1
EC50 = 120 nM
   TI
   LI
   LO
   TS